London-based private equity advisory firm ADM Capital Europe’ Cibus Enterprise Fund (Cibus) has invested in the personalised health and wellness company Rem3dy Health Limited, (Remedy Health).
Remedy Health was formed in May 2019 and raised their USD 2.75 million seed round by the end of 2019, the largest seed round ever raised by a female founder in the United Kingdom.
The company has now raised USD 11 million in Series A funding after seeing their revenues grow by more than 600 per cent over the past year.
The business develops patented 3D printing technologies which it uses to enable the production of personalised health and wellness solutions.
Melissa Snover, CEO of Remedy Health, says: “There has been a huge rise in the number of personalised nutrition products launched over the past few years, with the global industry predicted to go from USD3.7 billion in 2019 to over USD16 billion in 2027. Our goal at Remedy is to offer truly personalised nutrition in a single daily format; we utilise our patented 3D printing technology to achieve this, something no one else in the world can do. We provide the highest quality active ingredients available to support every individual’s specific needs and goals.”
Read more/Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.